Trial
NCT04672876
Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Neuroendocrine Tumors
Intervention
Telotristat Ethyl Oral Tablet
Why stopped
Trial funding no longer available.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-17